NIAID and Battelle partner on assays to improve COVID-19 vaccine analysis


Funded by the National Institutes of Health (NIH), researchers at Department of Energy (DOE) partner Battelle have developed a microneutralization assay that uses live SARS-CoV-2 virus to analyze the neutralizing response against the virus in human serum samples. The assay is particularly useful for testing samples from vaccine clinical trials.

Read more about this news here.

Related articles

Recent articles